Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Johannes Huss-Marp"'
Autor:
Sylke Schneider-Burrus, Athanasia Tsaousi, Sebastian Barbus, Johannes Huss-Marp, Katrin Witte, Kerstin Wolk, Björn Fritz, Robert Sabat
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with an adverse impact on patients' quality of life (QoL).Objectives: To quantify QoL impairment in patients in Germany suffering from HS and to identify the parameters
Externí odkaz:
https://doaj.org/article/cec4acdda6c14025b61a2e72cd107224
Publikováno v:
Allergo Journal. 24:18-25
Allergenkomponenten bieten prinzipiell drei Moglichkeiten, die In-vitro-IgE-Diagnostik zu erweitern: a) Allergenkomponenten konnen einzeln zur IgE-Bestimmung verwendet werden. b) Sie konnen in einem Test als Mix kombiniert werden. c) Einzelne Allerge
Publikováno v:
Allergo Journal International. 24:236-243
Essentially, allergen components offer three possibilities to improve in vitro IgE diagnostics: Allergen components can be used individually for IgE determination. Allergen components can be combined as a mix in one test. Individual allergen componen
Autor:
G. I. Athanasiadis, Johannes Huss-Marp, Vitaly Napadow, Peter C. Schalock, Florian Pfab, Johannes Ring
Publikováno v:
Expert Review of Clinical Immunology. 10:831-841
This review summarizes current evidence for acupuncture treatment of allergies. Several randomized controlled trials have demonstrated a specific effect of acupuncture for allergic rhinitis; while a few studies have shown positive effects for atopic
Autor:
Thilo Jakob, Heidrun Behrendt, Carl Johan Petersson, J. Ring, Johannes Huss-Marp, Knut Brockow, Florian Pfab, Ulf Darsow, Magnus P. Borres
Publikováno v:
Clin. Exp. Allergy 44, 778-786 (2014)
BACKGROUND: Data on molecular allergy diagnostics in adults with grass pollen allergy with regard to conjunctival and nasal provocation test outcome and specific immunotherapy is lacking to date. OBJECTIVE: To assess whether molecular allergy diagnos
Autor:
G. I. Athanasiadis, Johannes Huss-Marp, Vitaly Napadow, Peter C. Schalock, Johannes Ring, Florian Pfab
Publikováno v:
Focus on Alternative and Complementary Therapies. 18:77-84
Objective Complementary and alternative medicine (CAM) is a conservative and increasingly popular approach to atopic diseases for both patients and medical providers. Over the past few decades, there has been increased research activity into the use
Autor:
Michaela Miehe, Jörg Fischer, Markus Ollert, Edzard Spillner, Franziska Ruëff, Wolfgang Pfützner, Britta Dorn, D. Wieczorek, Johannes Huss-Marp, Thilo Jakob, Arthur Helbling, Tilo Biedermann, Gerta Ruecker, Jonas Lidholm, Marcel Frick, Sabine Müller, Frank I. Bantleon
Publikováno v:
Frick, M, Fischer, J, Helbing, A, Ruëff, F, Wieczorek, D, Ollert, M, Pfützner, W, Müller, S, Huss-Marp, J, Dorn, B, Biedermann, T, Lidholm, J, Rücker, G, Bantleon, F, Miehe, M, Spillner, E & Jakob, T 2016, ' Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy ', Journal of Allergy and Clinical Immunology, vol. 138, no. 6, pp. 1663-1671e9 . https://doi.org/10.1016/j.jaci.2016.04.024
Frick, M, Fischer, J, Helbling, A, Ruëff, F, Wieczorek, D, Ollert, M, Pfützner, W, Müller, S, Huss-Marp, J, Dorn, B, Biedermann, T, Lidholm, J, Ruecker, G, Bantleon, F, Miehe, M, Spillner, E & Jakob, T 2016, ' Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy ', Journal of Allergy and Clinical Immunology, vol. 138, no. 6, pp. 1663-1671.e9 . https://doi.org/10.1016/j.jaci.2016.04.024
Frick, Marcel; Fischer, Jörg; Helbling, Arthur; Ruëff, Franziska; Wieczorek, Dorothea; Ollert, Markus; Pfützner, Wolfgang; Müller, Sabine; Huss-Marp, Johannes; Dorn, Britta; Biedermann, Tilo; Lidholm, Jonas; Ruecker, Gerta; Bantleon, Frank; Miehe, Michaela; Spillner, Edzard; Jakob, Thilo (2016). Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. Journal of allergy and clinical immunology, 138(6), 1663-1671.e9. Elsevier 10.1016/j.jaci.2016.04.024
Frick, M, Fischer, J, Helbling, A, Ruëff, F, Wieczorek, D, Ollert, M, Pfützner, W, Müller, S, Huss-Marp, J, Dorn, B, Biedermann, T, Lidholm, J, Ruecker, G, Bantleon, F, Miehe, M, Spillner, E & Jakob, T 2016, ' Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy ', Journal of Allergy and Clinical Immunology, vol. 138, no. 6, pp. 1663-1671.e9 . https://doi.org/10.1016/j.jaci.2016.04.024
Frick, Marcel; Fischer, Jörg; Helbling, Arthur; Ruëff, Franziska; Wieczorek, Dorothea; Ollert, Markus; Pfützner, Wolfgang; Müller, Sabine; Huss-Marp, Johannes; Dorn, Britta; Biedermann, Tilo; Lidholm, Jonas; Ruecker, Gerta; Bantleon, Frank; Miehe, Michaela; Spillner, Edzard; Jakob, Thilo (2016). Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. Journal of allergy and clinical immunology, 138(6), 1663-1671.e9. Elsevier 10.1016/j.jaci.2016.04.024
BACKGROUND: Component resolution recently identified distinct sensitization profiles in honey bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or Api m 10, which have been reported to be underrepresented in therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::441851c8601aa8d2ccdd21e3cb3a3cdb
https://pure.au.dk/portal/da/publications/predominant-api-m-10-sensitization-as-risk-factor-for-treatment-failure-in-honey-bee-venom-immunotherapy(2cacc4db-616c-497b-9770-41e6f5a40fad).html
https://pure.au.dk/portal/da/publications/predominant-api-m-10-sensitization-as-risk-factor-for-treatment-failure-in-honey-bee-venom-immunotherapy(2cacc4db-616c-497b-9770-41e6f5a40fad).html
Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis
Autor:
Ina Schäffner, Ulf Darsow, Johannes Huss-Marp, Christoph Ahlgrim, Florian Pfab, Jan Gutermuth, Knut Brockow, Johannes Ring, Heidrun Behrendt, Thilo Jakob
Publikováno v:
Allergo Journal International
BACKGROUND: ImmunoCAP ISAC 112, is a commercially available molecular allergy IgE multiplex test. Data on the comparison of this rather novel test with extract-based as well as molecular ImmunoCAP singleplex IgE tests is missing. OBJECTIVE: To perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1113a5b6c759db5d59e29ef0c994c60
https://biblio.vub.ac.be/vubir/comparison-of-molecular-and-extractbased-allergy-diagnostics-with-multiplex-and-singleplex-analysis(ca38792b-a3ab-4788-b831-ddbb4d5cb6da).html
https://biblio.vub.ac.be/vubir/comparison-of-molecular-and-extractbased-allergy-diagnostics-with-multiplex-and-singleplex-analysis(ca38792b-a3ab-4788-b831-ddbb4d5cb6da).html
Autor:
Albrecht Will, Stefan Martinoff, Tareq Ibrahim, Fabian Blanke, Nikolas von Bubnoff, Johannes Huss-Marp, Albert Schömig
Publikováno v:
International Journal of Cardiology. 153:105-108
Autor:
Carl Johan Petersson, J. Ring, Wolfgang Schober, Ulf Darsow, Florian Pfab, Johannes Huss-Marp, Magnus P. Borres, Heidrun Behrendt, Knut Brockow, Ingrid Weichenmeier
Publikováno v:
Clinical & Experimental Allergy. 41:1116-1124
Summary Background There is minimal data available concerning the dose–response relationship between allergen exposure and clinical reactivity for outdoor aeroallergens, such as timothy grass pollen. Timothy pollen-specific IgE (sIgE) determination